Navigation Links
Hillenbrand, Inc. Increases Quarterly Dividend to $0.185 Per Share
Date:12/5/2008

BATESVILLE, Ind., Dec. 5 /PRNewswire-FirstCall/ -- The board of directors for Hillenbrand, Inc. (NYSE: HI) has declared a regular quarterly cash dividend of $0.185 per share on the company's common stock, a 1.4 percent increase over the previous quarterly rate of $0.1825 per share. The dividend is payable Dec. 31, 2008, to shareholders of record at the close of business on Dec. 17, 2008. Hillenbrand has paid quarterly dividends since its debut as a separate public company in April 2008, beginning with its first payout in June of this year.

"The board's decision to increase the dividend reflects its confidence in the company's continued financial strength and in our future," said Kenneth A. Camp, Hillenbrand president and CEO. "Our annual dividend payout of more than $45 million, combined with our share repurchase program, reflects our commitment to return a meaningful portion of our strong cash flow to shareholders."

ABOUT HILLENBRAND, INC.

Hillenbrand, Inc. ( www.HillenbrandInc.com ) is the holding company for Batesville Casket Company, a leader in the North American death care industry through the sale of funeral services products, including burial caskets, cremation caskets, containers and urns, selection room display fixturing and other personalization and memorialization products. HI-INC-F


'/>"/>
SOURCE Hillenbrand, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Hillenbrand, Inc. Declares First Quarterly Dividend As a New Publicly Traded Company
2. Hillenbrand, Inc. Names Joe A. Raver President and Chief Operating Officer of Batesville Casket Company
3. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
4. Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42
5. Hillenbrand, Inc. Announces Analyst/Investor Conference in New York Dec. 3
6. Hillenbrand, Inc. Announces Fourth-Quarter Earnings Release Date and Conference Call
7. Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31
8. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
9. Fat on chest and upper back increases risk of insulin resistance
10. Handling Stress Properly Increases Good Cholesterol
11. High alcohol consumption increases stroke risk among Chinese men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... related services to families and business owners across eastern Michigan, is connecting with ... families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ...
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge ... now offering treatments for sleep apnea and TMJ at their office. TMJ, or ... , specifically the obstructive type, is increasingly being treated at dental offices with ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ... prep patients for colonoscopy at the HyGIeaCare® Center that is to be located ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug ...
(Date:3/24/2017)... , ... March 24, 2017 , ... “End Time GPS”: ... salient events will interrelate. “End Time GPS” is the creation of published author, ... expert while working on military munitions and space-vehicle projects. Now, at age ninety-one, he ...
(Date:3/23/2017)... , ... March 23, 2017 , ... In 2016 the ... estimates that there could be four million Zika-related cases in the Americas within the ... numbers of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... YORK , March 24, 2017   ... leading organization within medical affairs in the pharmaceutical ... as the chair of a newly formed scientific ... board members to form the first ever medical ... For more information about the ACMA, please ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
(Date:3/24/2017)... Today Stock-Callers.com have issued research reports ... Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. ... ). These companies are part of the Healthcare sector, which ... 23 rd , 2017, with the NYSE Health Care Index ... companies in the S&P 500 were down about 0.4% as ...
Breaking Medicine Technology: